Lonza Forms Agreement to Manufacture Acumen Pharmaceuticals’ AD mAb Therapy April 5, 2024 AutoBot News 0 Under a collaboration agreement, Lonza will manufacture sabirnetug, Acumen Pharmaceuticals’ mAb in clinical development for treating Alzheimer’s disease.